Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extra hydration to protect kidney function during carboplatin + pemetrexed + pembrolizumab for advanced non-small cell lung cancer
2022-001975-15Phase 4Active
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of pemetrexed in non-small cell lung cancer (NSCLC). Primary endpoint: Acute kidney disease incidence. Started Jul 2022; status: active.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2022-001975-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-001975-15.